These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19016148

  • 1. Changes in red blood cells membrane protein composition during hemodialysis procedure.
    Costa E, Rocha S, Rocha-Pereira P, Castro E, Miranda V, Faria Mdo S, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Ren Fail; 2008; 30(10):971-5. PubMed ID: 19016148
    [Abstract] [Full Text] [Related]

  • 2. Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy.
    Costa E, Rocha S, Rocha-Pereira P, Castro E, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Blood Purif; 2008; 26(3):267-73. PubMed ID: 18417959
    [Abstract] [Full Text] [Related]

  • 3. Modifications in erythrocyte membrane protein content are not responsible for the alterations in rheology seen in sepsis.
    Piagnerelli M, Cotton F, Van Nuffelen M, Vincent JL, Gulbis B.
    Shock; 2012 Jan; 37(1):17-21. PubMed ID: 21941224
    [Abstract] [Full Text] [Related]

  • 4. Complete correction of renal anemia by recombinant human erythropoietin.
    Ludat K, Paulitschke M, Riedel E, Hampl H.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
    Costa E, Rocha S, Rocha-Pereira P, Nascimento H, Castro E, Miranda V, Faria Mdo S, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Am J Nephrol; 2008 Feb; 28(6):935-40. PubMed ID: 18587235
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure.
    Pereira R, Costa E, Gonçalves M, Miranda V, do Sameiro Faria M, Quintanilha A, Belo L, Lima M, Santos-Silva A.
    Hemodial Int; 2010 Jul; 14(3):295-301. PubMed ID: 20649681
    [Abstract] [Full Text] [Related]

  • 7. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E, Pereira BJ, Rocha-Pereira P, Rocha S, Reis F, Castro E, Teixeira F, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A.
    Am J Nephrol; 2008 Jul; 28(4):677-83. PubMed ID: 18354252
    [Abstract] [Full Text] [Related]

  • 8. Effect of chronic kidney disease on red blood cell rheology.
    Brimble KS, McFarlane A, Winegard N, Crowther M, Churchill DN.
    Clin Hemorheol Microcirc; 2006 Jul; 34(3):411-20. PubMed ID: 16614465
    [Abstract] [Full Text] [Related]

  • 9. Rat antibodies to spectrin, the principal inner component of erythrocyte membrane. Immunochemical studies after SDS-gel electrophoresis.
    Berti G, Govoni M.
    Boll Ist Sieroter Milan; 1986 Jul; 65(4):309-18. PubMed ID: 3790278
    [Abstract] [Full Text] [Related]

  • 10. [Abnormal changes in erythrocyte membrane proteins in hereditary spherocytosis and their relation to clinical and biological aspects of the disease].
    Ayala S, Besson I, Aymerich M, Berga L, Vives Corrons JL.
    Med Clin (Barc); 1995 Jun 10; 105(2):45-9. PubMed ID: 7603093
    [Abstract] [Full Text] [Related]

  • 11. Protein 7.2b of human erythrocyte membranes binds to calpromotin.
    Moore RB, Shriver SK.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):294-7. PubMed ID: 9125167
    [Abstract] [Full Text] [Related]

  • 12. [Protein changes of the erythrocyte membrane during blood preservation].
    Stibenz D, Brox D, Geyer G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980 Mar 17; 107(3):459-71. PubMed ID: 6159283
    [Abstract] [Full Text] [Related]

  • 13. Further characterization of the erythrocyte membrane protein abnormality in megaloblastic anemia.
    Ballas SK, Pielichowski HJ, Stoll DB.
    J Med; 1982 Mar 17; 13(1-2):15-34. PubMed ID: 6956651
    [Abstract] [Full Text] [Related]

  • 14. Band 3 is a target protein of spectrin's E2/E3 activity: implication for sickle cell disease and normal red blood cell aging.
    Chang TL, Cubillos FF, Kakhniashvili DG, Goodman SR.
    Cell Mol Biol (Noisy-le-grand); 2004 Mar 17; 50(2):171-7. PubMed ID: 15095787
    [Abstract] [Full Text] [Related]

  • 15. [Contents of the main erythrocyte membrane proteins in patients with primary arterial hypertension and its relationship with hereditary predisposition to cardiovascular diseases].
    Ivanov VP, Polonikov AV, Solodilova MA, Lukashov AA.
    Ter Arkh; 2000 Mar 17; 72(9):73-6. PubMed ID: 11076426
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interaction of DNR and glutaraldehyde with cell membrane proteins leads to morphological changes in erythrocytes.
    Marczak A, Jóźwiak Z.
    Cancer Lett; 2008 Feb 18; 260(1-2):118-26. PubMed ID: 18060688
    [Abstract] [Full Text] [Related]

  • 18. Alterations of red blood cell shape and sialic acid membrane content in septic patients.
    Piagnerelli M, Boudjeltia KZ, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P, Vanhaeverbeek M.
    Crit Care Med; 2003 Aug 18; 31(8):2156-62. PubMed ID: 12973174
    [Abstract] [Full Text] [Related]

  • 19. Chronology of the formation of vesicles and membrane protein aggregates during erythrocyte aging.
    Ghailani N, Guillemin C, Vigneron C.
    Nouv Rev Fr Hematol (1978); 1995 Aug 18; 37(6):313-9. PubMed ID: 8907625
    [Abstract] [Full Text] [Related]

  • 20. The contribution of genetic and environmental factors to quantitative variability of erythrocyte membrane proteins in primary hypotension.
    Ivanov VP, Polonikov AV, Solodilova MA.
    Ann Hum Genet; 2005 Jan 18; 69(Pt 1):25-35. PubMed ID: 15638825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.